Sword Health
AI-guided physical, women's and mental health care sold through employers and health plans
Overview
Sword Health is a digital care company that pairs AI-guided sessions, led by its Phoenix AI Care specialist, with licensed clinicians across musculoskeletal pain (Thrive), women's health (Bloom), mental health (Mind) and cardiometabolic care (Pulse). It is sold to employers, health plans and unions on outcome-based pricing, and covered members pay nothing. Sword bought Kaia Health in January 2026 and agreed to buy Headspace in September 2026.
Pricing
Pricing shown for reference only. These figures reflect RECATOOLS research as of 14 Oct 2026 and may be out of date or incomplete. This is not financial or purchasing advice — always confirm the current price on the provider’s official website before making any decision.
- Thrive, Bloom, Mind and Pulse programmes
- AI Care sessions guided by Phoenix
- Licensed clinicians stepping in when needed
- 50% charged after the onboarding call or first session
- 50% billed only when a measurable clinical outcome is achieved
- Maximum $1,000 billed per member, unlimited sessions across programmes
Use cases
What you can produce with Sword Health
- At-home physical therapy programmes with motion tracking and real-time AI guidance
- A licensed clinician overseeing each member's care plan
- Women's health, menopause and pelvic care through Bloom
- Cardiometabolic care through Pulse and mental-health support through Mind
- Outcome-based invoicing tied to measurable member improvement
- One AI Care platform with shared clinical memory across programmes
ASEAN Perspective
Sword Health in Southeast Asia
Sword Health is primarily a North American and, increasingly, European product; ASEAN employees can only access it if their multinational employer holds a US or global contract with Sword. An Australian domain (au.swordhealth.com) exists, suggesting a commercial presence in ANZ, but no publicly confirmed distribution through regional health insurers or government schemes in Southeast Asia has been identified as of mid-2026. The January 2026 acquisition of Kaia Health prioritised German statutory reimbursement, not APAC. Employers in Singapore, Malaysia, or Indonesia evaluating digital MSK benefits should verify regional eligibility and device-shipping logistics directly with Sword's enterprise sales team, as the sensor-kit model requires physical hardware delivery.
Sword's pricing model is its most distinctive feature for buyers: half the fee is billed only when a member reaches a measurable clinical outcome, with a $1,000-per-member cap. The programme range now spans musculoskeletal, women's, mental and cardiometabolic care on one platform, and the Kaia and pending Headspace deals add Germany and a large mental-health network.
Outcome and savings figures on its site are Sword's own, so procurement teams should define the outcome measure in the contract. Individuals can only use the core programmes through a sponsoring employer or plan. Strong choice for large US employers; little presence in Asia.
What we found
Sword Health began as digital physical therapy: members receive a tablet and motion sensors, follow guided exercise sessions at home, and a licensed physical therapist oversees the plan. It started in Porto, Portugal, and is headquartered in New York. Phoenix, which Sword calls its AI Care specialist, guides members through sessions, and the range has widened to Thrive for musculoskeletal pain, Bloom for women's health, Mind for mental health and, from March 2026, Pulse for cardiometabolic care. That month Sword also launched Dawn, an AI mental-health app it describes as its first direct-to-consumer product, and joined its programmes into one AI Care platform with shared clinical memory.
Growth is coming through acquisitions. In January 2026 Sword bought Kaia Health for $285 million, replacing Kaia's US musculoskeletal product with its own and gaining Kaia's place in Germany's digital-health reimbursement system. On 16 September 2026 it signed a definitive agreement to buy Headspace in an all-cash deal valued at up to $300 million, expected to close at the beginning of the fourth quarter; no closing announcement had been found by 14 October. Sword says it serves more than 2,500 enterprise clients and has treated over a million people with AI Care.
Most financial figures are self-reported. In June 2025 TechCrunch reported a $40 million raise at a $4 billion valuation, a $240 million annual revenue run rate, cash-flow-positive operations and an IPO pushed back to 2028 at the earliest. In January 2026 the chief executive, Virgílio Bento, said Sword was seeking about $500 million more; no closed round was found.
Individuals cannot buy the core programmes. Employers, health plans and unions contract with Sword, and covered members pay nothing. Sword's outcome pricing charges half the fee after onboarding and half only when a measurable clinical outcome is reached, capped at $1,000 a member. Sword's website blocked automated reading during this review, so its product pages were read from archived 2026 copies.
Compiled by RECATOOLS from public sources: vendor documentation and pricing, code repositories and published reporting.
Notable facts
- Sword Health's name traces back to its founders' university project: the Stroke Wearable Operative Rehabilitation Device (S.W.O.R.D.), which used 3D motion sensors to aid stroke rehabilitation at Universidade de Aveiro, Portugal.
- CEO Virgílio Bento's inspiration came from watching his brother's 12-year recovery from a car-accident coma, making the difficulty of accessing physiotherapy personally vivid from childhood.
- Phoenix, launched June 2024, is positioned as the first conversational AI care specialist to operate within a clinician-set treatment plan in real time, adapting verbal coaching mid-session based on member feedback.
- The January 2026 acquisition of Kaia Health for USD 285 million gives Sword access to Germany's GKV statutory health insurance system, covering over 70 million people — its first move into government-reimbursed digital therapeutics.
Frequently asked questions
About this listing
This entry was compiled from publicly available data including Sword Health's official website, press releases, documentation, and reputable third-party publications. RECATOOLS is not affiliated with Sword Health unless explicitly stated.
Third-party AI tools update their pricing, features, availability, and policies frequently. Information here may be outdated by the time you read this — we make reasonable efforts to keep listings current, but cannot guarantee absolute accuracy.
For the latest details, please refer to Sword Health directly →
Spotted something out of date? Suggest an update →
More in Healthcare
